Borch-Johnsen K
Steno Diabetes Centre, Gentofte, Denmark.
Diabetes Care. 1999 Mar;22 Suppl 2:B1-3.
Individuals with type 1 diabetes applying for insurance (life, health, accident, etc.) may either see their application being declined by the insurance company or find their premiums being substantially higher than the standard premium. During the last 40-50 years, the prognosis of patients with type 1 diabetes has improved dramatically, partly as a consequence of improved metabolic regulation and partly due to introduction of better treatment for late diabetic complications. The aim of the present study was to determine whether the increased premiums paid by diabetic patients for life insurance and accident insurance reflect the true risk of a diabetic individual.
Mortality: 3,000 type 1 diabetic patients were followed for 12-51 years. The impact of age, sex, year of diagnosis, and development of nephropathy on excess mortality was analyzed. Accidents: A cohort of nearly 7,000 members of the Danish Diabetes Association participating in group accident insurance was followed for 3 years. The risk and outcome of accidents in the diabetic group was compared with similar risks in a nondiabetic group.
Mortality: Over a 40-year period, the median life expectancy of type 1 diabetic patients increased by more than 15 years. The decrease was predominantly explained by a decreasing incidence of nephropathy, so that a simple model for estimating insurance premiums (including age of diagnosis, sex, and presence or absence of diabetic nephropathy) could be established. Accident insurance: Individuals with type 1 diabetes experienced a risk of accidents that was not in excess of that found in two control groups, and the outcome (degree of disability) after the accidents did not differ between the diabetic and the nondiabetic group.
Type 1 diabetic patients still have a mortality in excess of nondiabetic individuals. Life insurance premiums should, however, always reflect the changing prognosis of type 1 diabetes and thus, continuous monitoring and revisions are needed. For accident insurance, we found no increased risk of accidents; thus, diabetic individuals should be offered accident insurance on normal terms.
申请保险(人寿、健康、意外等)的1型糖尿病患者可能会发现其申请被保险公司拒绝,或者发现其保费远高于标准保费。在过去40到50年里,1型糖尿病患者的预后有了显著改善,部分原因是代谢调节的改善,部分原因是引入了更好的糖尿病晚期并发症治疗方法。本研究的目的是确定糖尿病患者支付的人寿保险和意外保险保费增加是否反映了糖尿病个体的真实风险。
死亡率:对3000例1型糖尿病患者进行了12至51年的随访。分析了年龄、性别、诊断年份和肾病发展对超额死亡率的影响。意外事故:对近7000名参加团体意外保险的丹麦糖尿病协会成员进行了3年的随访。将糖尿病组的意外风险和结果与非糖尿病组的类似风险进行了比较。
死亡率:在40年的时间里,1型糖尿病患者的中位预期寿命增加了超过15岁。这种下降主要是由于肾病发病率的降低,因此可以建立一个估计保险费的简单模型(包括诊断年龄、性别和是否存在糖尿病肾病)。意外保险:1型糖尿病患者经历的意外风险并不高于两个对照组,糖尿病组和非糖尿病组意外事故后的结果(残疾程度)没有差异。
1型糖尿病患者的死亡率仍然高于非糖尿病个体。然而,人寿保险费应始终反映1型糖尿病不断变化的预后,因此需要持续监测和修订。对于意外保险,我们没有发现意外风险增加;因此,应该以正常条款为糖尿病患者提供意外保险。